Exact Mass: 431.0569372
Exact Mass Matches: 431.0569372
Found 81 metabolites which its exact mass value is equals to given mass value 431.0569372,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Rimsulfuron
CONFIDENCE standard compound; EAWAG_UCHEM_ID 130 EAWAG_UCHEM_ID 130; CONFIDENCE standard compound
4-Ketoanhydrochlortetracycline
C20H14ClNO8 (431.04079140000005)
Pimasertib
C15H15FIN3O3 (431.01421619999996)
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C69145 - Mitogen-Activated Protein Kinase Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor Pimasertib (AS703026) is a highly selective, ATP non-competitive allosteric orally available MEK1/2 inhibitor[1][2].
[[(2r,3s,4r,5r)-5-(4-Azanyl-2-Oxidanylidene-Pyrimidin-1-Yl)-3,4-Bis(Oxidanyl)oxolan-2-Yl]methoxy-Oxidanyl-Phosphoryl]oxy-(2-Hydroxyethyl)phosphinic Acid
C11H19N3O11P2 (431.04948039999994)
Albaconazole
C20H16ClF2N5O2 (431.09605300000004)
2-Fluorobutyl 2-(8-azabicyclo[3.2.1]octan-1-yl)-5-iodobenzoate
C18H23FINO2 (431.07574999999997)
Ioflupane
C18H23FINO2 (431.07574999999997)
8-Acetamido-1,1,1,15,15-pentachloropentadeca-3,12-diyne
4-Dedimethylamine-4-oxo-anhydro-7-Cl-tetracycline
C20H14ClNO8 (431.04079140000005)
(E)-6-Iodo-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole
C19H18IN3O (431.04945680000003)
(4Z)-4-[(3-chlorophenyl)hydrazinylidene]-N-(2-methoxyphenyl)-3-oxonaphthalene-2-carboxamide
C24H18ClN3O3 (431.10366280000005)
4-(2-CHLORO-6-((4-(METHYLSULFONYL)PIPERAZIN-1-YL)METHYL)THIENO[3,2-D]PYRIMIDIN-4-YL)MORPHOLINE
C16H22ClN5O3S2 (431.08525319999995)
Thiazolidine, 2-(2-chlorophenyl)-3-[(4-phenoxyphenyl)sulfonyl]- (9CI)
Pyrido[2,3-d]pyrimidine-2,4,7(1H,3H,8H)-trione,5-azido-8-methyl-6-nitro-1,3-diphenyl-
C20H13N7O5 (431.09781280000004)
3-IODO-N-ISOBUTYL-1-(((TRIMETHYLSILYL)METHOXY)METHYL)-1H-PYRROLO[2,3-B]PYRIDIN-4-AMINE
BTZ043
C17H16F3N3O5S (431.07627220000006)
2-[(6-amino-1-hydroxy-3-sulpho-2-naphthyl)azo]benzoic acid, sodium salt
N-(2-CARBOXY-4,5-DICHLOROBENZOYL)-(-)-10,2-CAMPHORSULTAM
C18H19Cl2NO5S (431.0360944000001)
N-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)-3-(4-(PYRIDIN-3-YLOXY)PHENYL)-1H-1,2,4-TRIAZOL-5-AMINE
C20H13ClF3N5O (431.07606740000006)
ETHYL [3-(4-BROMOPHENYL)-4,6-DIMETHOXY-1H-INDOL-7-YL]-OXO-ACETATE
(S)-1-(tert-Butoxycarbonyl)-2-(4-iodobenzyl)pyrrolidine-2-carboxylic acid
C17H22INO4 (431.05935220000003)
1-[4-BROMO-2-(HYDROXYMETHYL)PHENYL]-4-(DIMETHYLAMINO)-1-(4-FLUOROPHENYL) BUTAN-1-OL HYDROCHLORIDE
CYCLOPENTADIENYL(FLUORENE)IRON HEXAFLUOROPHOSPHATE
C18H14F6FeP (431.00866560000003)
(3S,5S,6R)-TERT-BUTYL 3-BROMO-2-OXO-5,6-DIPHENYLMORPHOLINE-4-CARBOXYLATE
C21H22BrNO4 (431.07321120000006)
Acetic acid, 2-[[5-bromo-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]-, ethyl ester
(((2-(6-aMino-9H-purin-9-yl)ethoxy)Methyl)phosphoryl)bis(oxy)bis(Methylene) isopropyl dicarbonate
ethyl 5-(benzyloxy)-6-broMo-2-(2-hydroxyethyl)-1-Methyl-1H-indole-3-carboxylate
C21H22BrNO4 (431.07321120000006)
4-Iodo-4,4-dimethoxytriphenylamine
C20H18INO2 (431.03822379999997)
Albaconazole
C20H16ClF2N5O2 (431.09605300000004)
D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent
Ioflupane I-123
C18H23FINO2 (431.07574999999997)
V - Various > V09 - Diagnostic radiopharmaceuticals > V09A - Central nervous system > V09AB - Iodine (123i) compounds C1446 - Radiopharmaceutical Compound
[(1s)-1-(5-Chloro-1-Benzothien-3-Yl)-2-(2-Naphthylamino)-2-Oxoethyl]phosphonic Acid
C20H15ClNO4PS (431.0147910000001)
Vitexin-7-olate
C21H19O10- (431.09781740000005)
Conjugate base of vitexin arising from deprotonation of the 7-hydroxy group; major species at pH 7.3.
7-alpha-hydroxy-O-carbamoyl-deacetylcephalosporin C
3-(beta-D-glucopyranosyloxy)-55,7-dihydroxy-2-(4-hydroxyphenyl)-1-benzopyrylium chloride
C21H19O10- (431.09781740000005)
2-[2-[2-[[(2S)-2-(2-carboxylato-2-hydroxy-5-oxopyrrolidin-1-yl)propanoyl]amino]ethoxy]-2-oxoethyl]-2-hydroxybutanedioate
(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-1-oxo-3-(2,4,5-trihydroxyphenyl)sulfanylpropan-2-yl]amino]-5-oxopentanoic acid
C16H21N3O9S (431.09984560000004)
3-Phenyl-5-[[[4-phenyl-5-(thiophen-2-ylmethyl)-1,2,4-triazol-3-yl]thio]methyl]-1,2,4-oxadiazole
N-[4-[[[(3-bromo-4-methylphenyl)-oxomethyl]hydrazo]-oxomethyl]phenyl]pentanamide
[5-(4-Chlorophenyl)-1,3,4-oxadiazol-2-yl]-[4-(1-piperidinylsulfonyl)phenyl]methanone
C20H18ClN3O4S (431.07064980000007)
apigenin 7-O-beta-D-glucoside(1-)
C21H19O10- (431.09781740000005)
A flavonoid oxoanion that is the conjugate base of apigenin 7-O-beta-D-glucoside, obtained by deprotonation of the 7-hydroxy group. Major microspecies at pH 7.3 (according to Marvin v 6.2.0.).
3-Nitro-4-[[4-(2-oxolanylmethyl)-5-thiophen-2-yl-1,2,4-triazol-3-yl]thio]benzamide
N-[4-(2,5-dimethoxyphenyl)-2-thiazolyl]-2-[(4-nitrophenyl)thio]acetamide
2-(2,3-Dihydro-1,4-benzodioxin-6-ylsulfonylamino)benzoic acid thiophen-2-ylmethyl ester
4-((E)-3-Oxo-3-pyridin-3-yl-propenylamino)-N-quinoxalin-2-yl-benzenesulfonamide
N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]-2-(trifluoromethyl)benzamide
7-(beta-D-glucopyranosyloxy)-3-(4-hydroxyphenyl)-4-oxo-4H-1-benzopyran-5-olate
C21H19O10- (431.09781740000005)
(2S,3S,4S,5R)-6-[[3-Amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-5-yl]amino]-3,4,5-trihydroxyoxane-2-carboxylic acid
(2E,5Z)-5-[(3-bromophenyl)methylidene]-2-[(E)-(1,7,7-trimethyl-2-bicyclo[2.2.1]heptanylidene)hydrazinylidene]-1,3-thiazolidin-4-one
C20H22BrN3OS (431.06668620000005)
CMP-5-phosphonoformic acid
C10H15N3O12P2 (431.01309699999996)
A cytidine 5-phosphate obtained by formal condensation of the phosphate group of CMP with the phosphono group of phosphonoformic acid.
afzelin(1-)
C21H19O10 (431.09781740000005)
A flavonoid oxonion resulting from the deprotonation of the hydroxy group at position 7 of the flavone moiety of afzelin (kaempferol 3-O-alpha-L-rhamnoside). The major species at pH 7.3.
Vibrioferrin(3-)
A tricarboxylic acid trianion resulting from the deprotonation of all three carboxy groups of vibrioferrin. The major species at pH 7.3.
Dedimethylamineoxo-anhydroCl-tetracycline
C20H14ClNO8 (431.04079140000005)
EX229
C24H18ClN3O3 (431.10366280000005)
EX229, a Benzimidazole derivative, is a potent and allosteric activator of AMP-activated protein kinase (AMPK), with Kds of 0.06 μM, 0.06 μM and 0.51 μM for α1β1γ1, α2β1γ1 and α1β2γ1 in biolayer interferometry, respectively.
TP0463518
TP0463518 is a potent hypoxia-inducible factor prolyl hydroxylases (PHDs) inhibitor with a Ki value of 5.3 nM for human PHD2. TP0463518 also inhibits human PHD1/PHD3 with IC50s of 18 and 63 nM as well as monkey PHD2 with an IC50 value of 22 nM[1].
Anthocyanidin 3-O-beta-D-glucoside
C21H19O10 (431.09781740000005)
(4as,5s,12as)-1,4a,5,10,11,12a-hexahydroxy-8-methoxy-3,12-dioxo-4,5-dihydrotetracene-2-carboximidic acid
C20H17NO10 (431.08524220000004)
n-[(8r)-1,1,1,15,15-pentachloropentadeca-3,12-diyn-8-yl]ethanimidic acid
[(e)-(6-oxo-1-{[(2r,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}octylidene)amino]oxysulfonic acid
C14H25NO10S2 (431.09198299999997)
(4as,5s,12as)-3,4a,5,10,11,12a-hexahydroxy-8-methoxy-1,12-dioxo-4,5-dihydrotetracene-2-carboximidic acid
C20H17NO10 (431.08524220000004)
(2s)-2-amino-3-(6-bromo-1h-indol-3-yl)-n-[(1e)-2-(3,4,5-trihydroxyphenyl)ethenyl]propanimidic acid
C19H18BrN3O4 (431.04806080000003)
n-(1,1,1,15,15-pentachloropentadeca-3,12-diyn-8-yl)ethanimidic acid
2-amino-3-(6-bromo-1h-indol-3-yl)-n-[2-(3,4,5-trihydroxyphenyl)ethenyl]propanimidic acid
C19H18BrN3O4 (431.04806080000003)